Dyne Therapeutics Inc (DYN)
Healthcare
Biotechnology
25.20 $
+0.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Dyne Therapeutics Inc (DYN) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 07/29/2026 | Current report (8-K) | Dyne Therapeutics, Inc. (DYN): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report → |
| 07/27/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/22/2026 | Current report (8-K) | Dyne Therapeutics, Inc. (DYN): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits | View report → |
| 07/22/2026 | Capital measure | Form 424B5 filed with the SEC | View document → |
| 07/21/2026 | Capital measure | Form 424B5 filed with the SEC | View document → |
| 07/20/2026 | Current report (8-K) | Dyne Therapeutics, Inc. (DYN): Other Events | View report → |
| 07/07/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/07/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/07/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/07/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/06/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/06/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/06/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.